Citius Pharmaceuticals, Inc. — Director's Dealing 2016

Apr 12, 2016

SEC Form 3/A — Form 3/A

Issuer: Citius Pharmaceuticals, Inc. (CTXR)
CIK: 0001506251
Period of Report: 2014-09-12-06:00

Reporting Person: Mazur Leonard L (N/A)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Options to Purchase Common Stock	$0.45	2024-09-12-06:00	Common Stock (1500000)		Direct

Footnotes

F1: On October 28, 2015, the Reporting Person filed a Form 3 with the Commission. The Form 3 included an option to purchase 1,300,000 shares of common stock of the Issuer (the "Common Stock"); however, the grant was for an option to purchase 3,300,000 shares of common Stock. Accordingly, the previously filed Form 3 omitted the option to purchase an additional 1,500,000 shares of Common Stock. The option to purchase an aggregate of 3,300,000 shares of Common Stock shall vest and become exercisable as follows: (i) the option to purchase 1,300,000 shares of Common Stock vested on September 12, 2014, (ii) the option to purchase 500,000 shares of Common Stock vested on September 12, 2015, (iii) the option to purchase 500,000 shares of Common Stock vested on March 12, 2016 (iv) the option to purchase 500,000 shares of Common Stock shall vest on September 12, 2016 and (v) the option to purchase 500,000 shares of Common Stock shall vest on September 12, 2017. The option was issued pursuant to the Company's 2014 Stock Incentive Plan.